GlassScriptPhysician profile
Amy L Brooks
NPI 1336332162
$3,876.95
in general payments reported to CMS, 2019-2025
46 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,358 · 2022: $928 · 2023: $753 · 2024: $564 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,591.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $488.10 | 2021-2025 | |
| Novo Nordisk INC | $451.62 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Mayne Pharma Commercial LLC | $436.04 | 2021-2025 | |
| Astellas Pharma US INC | $377.77 | 2021-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $236.38 | 2021-2023 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $216.99 | 2021-2024 | Trulance, Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $166.77 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $161.17 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $110.51 | 2023-2025 | Myfembree |
| Organon LLC | $98.30 | 2022-2025 | Nexplanon |
| Lilly USA, LLC | $92.73 | 2021-2025 | Jardiance, Zepbound |
| Avion Pharmaceuticals | $84.28 | 2021-2023 | Balcoltra |
| Corcept Therapeutics | $65.49 | 2023-2024 | Korlym |
| Myovant Sciences INC. | $62.03 | 2021-2022 | |
| Amgen INC. | $55.24 | 2021 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.